SOM Biotech Company
SOM Biotech is a drug innovation company that utilizes a pioneering AI-based drug discovery technology called SOM AI PRO. The company focuses on developing drugs for Orphan CNS diseases, which have a high unmet need and blockbuster potential. SOM Biotech has successfully validated its AI technology with two Phase 2 trials and currently has four programs in the preclinical stage. The company not only uses its AI technology to advance drug candidates quickly but also identifies novel targets and indications for molecules, improving the effectiveness of drug discovery and management. Through strategic collaborations, SOM Biotech aims to bring its innovative drugs to market efficiently.
Industry:
Preclinical Development
Employee Number:
11-50
Founded Date:
2009
Headquarters:
Barcelona, Barcelonès, Barcelona, Catalonia, Spain